Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas

Br J Cancer. 1998 Aug;78(4):472-7. doi: 10.1038/bjc.1998.517.

Abstract

Midkine (MK) is a growth factor identified as a product of a retinoic acid-responsive gene. A truncated form of MK mRNA, which lacks a sequence encoding the N-terminally located domain, was recently found in cancer cells. We investigated the expression of the truncated MK mRNA in specimens of 47 surgically removed human gastrointestinal organs using polymerase chain reaction. Truncated MK was not detected in all of the 46 corresponding non-cancerous regions. On the other hand, this short MK mRNA was expressed in the primary tumours in 12 of 16 gastric cancers, 8 of 13 colorectal carcinomas, five of nine hepatocellular carcinomas, two of two oesophageal carcinomas and one ampullary duodenal cancer. In addition, truncated MK was detectable in all of the 14 lymph node metastases but in none of three metastatic sites in the liver, suggesting that truncated MK mRNA could become a good marker of nodal metastases in gastrointestinal tract.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Blotting, Northern
  • Carrier Proteins / analysis*
  • Carrier Proteins / genetics
  • Cytokines*
  • Female
  • Gastrointestinal Neoplasms / diagnosis*
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Midkine
  • Polymerase Chain Reaction
  • RNA, Messenger / analysis

Substances

  • Biomarkers, Tumor
  • Carrier Proteins
  • Cytokines
  • RNA, Messenger
  • Midkine